The cost-of-illness due to rheumatic heart disease: national estimates for Fiji

Rheumatic heart disease (RHD) is a chronic valvular heart disease that is responsible for a heavy burden of premature mortality in low- and middle-income countries. The total costs of RHD are important to health policy and research investment decisions. We estimate for the first time the total cost...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heenan, Rachel (VerfasserIn) , Parks, Tom (VerfasserIn) , Bärnighausen, Till (VerfasserIn) , Kado, Joseph (VerfasserIn) , Bloom, David E (VerfasserIn) , Steer, Andrew C (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 March 2020
In: Transactions of the Royal Society of Tropical Medicine and Hygiene
Year: 2020, Jahrgang: 114, Heft: 7, Pages: 483-491
ISSN:1878-3503
DOI:10.1093/trstmh/trz118
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/trstmh/trz118
Volltext
Verfasserangaben:Rachel C Heenan, Tom Parks, Till Bärnighausen, Joseph Kado, David E Bloom and Andrew C Steer
Beschreibung
Zusammenfassung:Rheumatic heart disease (RHD) is a chronic valvular heart disease that is responsible for a heavy burden of premature mortality in low- and middle-income countries. The total costs of RHD are important to health policy and research investment decisions. We estimate for the first time the total cost of RHD for Fiji (2008-2012) using a cost-of-illness approach and novel primary data on RHD disease burden and costs.RHD cases were identified using probabilistic record linkage across four routine data sources: (1) the Fiji RHD Control Program, (2) national hospital admissions records, (3) the Ministry of Health database of cause-specific deaths and (4) hospital ECG clinic registers. For each individual with RHD, we obtained information on RHD hospital admissions, treatment and death. We conducted a prevalence-based cost-of-illness analysis, including bottom-up assessment of indirect and direct (healthcare) costs.The estimated cost of RHD in Fiji for 2008-2012 was year-2010 $FJ91.6 million (approximately US$47.7 million). Productivity losses from premature mortality constituted the majority of costs (71.4%). Indirect costs were 27-fold larger than the direct costs.RHD leads to a heavy economic burden in Fiji. Improved prevention strategies for RHD will likely confer substantial economic benefits to the country.
Beschreibung:Gesehen am 05.02.2021
Beschreibung:Online Resource
ISSN:1878-3503
DOI:10.1093/trstmh/trz118